This program is intentionally structured for patients who want consistent support and meaningful progress
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)
H-RZ, H-XL, and C-YX performed the research
Combination of insulin-like growth factor-1, IGF binding protein-3, chromogranin A and prostate specific antigen can improve the detection of prostate cancer
Four populations were identified: viable (Annexin/PI), early apoptotic (Annexin+/PI), late apoptotic (Annexin+/PI+), and necrotic (Annexin/PI+)
Clearly, the currently used IPV and OPV have drawbacks in their manufacturing and application